Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments division of Essilor International, a subsidiary of EssilorLuxottica. Essilor International is the world’s leading ophthalmic optics… Continue reading Diagnos $ADK #DGNOF Signs Memorandum of Understanding with #Essilor International
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in… Continue reading Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE
Diagnos Inc. $ADK $DGNOF #AI #healthcare #technology #diabetics #blindness #StrokePrevention Interview: https://youtu.be/B7elDQ7bgb4 InvestorIntel Interview with Andre Larente, President of Diagnos Inc.
Diagnos Inc. $ADK and the 3rd Largest #optical Retailer in Costa Rica Piloting CARA and its #telemedicine #technology #Healthcare #diabetes #retinaldisease #AI #artificialintelligence #Hypertension #stroke #deeplearning https://www.globenewswire.com/news-release/2021/03/04/2187355/0/en/DIAGNOS-and-the-third-largest-optical-retailer-in-Costa-Rica-Piloting-CARA-and-its-Telemedicine-technology.html Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based… Continue reading Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology